MarketCap
Facebook
X
TelegramGenMark Diagnostics, Inc. Operating Expenses 2011-2026 | GNMK
Annual Operating Expenses GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 79 M | 70.4 M | 67.3 M | 79.5 M | 78.6 M | 65.6 M | 56.5 M | 46.4 M | 30.7 M | 22.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79.5 M | 22.7 M | 59.7 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
2.19 B | $ 173.14 | -0.8 % | $ 13 B |  USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 279.25 | 0.63 % | $ 7.88 B | USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 10.9 | -1.54 % | $ 1.64 B | USA |
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.17 | -0.41 % | $ 1.64 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | 0.84 % | $ 38 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.3 | -1.79 % | $ 124 M |  France |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 37.59 | -1.03 % | $ 5.6 K | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 61.79 | 0.83 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.89 | - | $ 1.15 M | USA |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.0 | -3.86 % | $ 16.9 M | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 8.68 | -3.12 % | $ 246 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.12 | -1.19 % | $ 204 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.97 | 0.19 % | $ 375 M | USA |
 |
Inogen
INGN
|
184 M | $ 6.33 | -4.95 % | $ 168 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 62.78 | -0.93 % | $ 3.42 B |  Britain |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.7 | 4.4 % | $ 68.2 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Globus Medical
GMED
|
547 M | $ 90.42 | -1.07 % | $ 12.2 B | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 4.11 | -0.96 % | $ 870 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.04 | 1.62 % | $ 360 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.69 | -1.43 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 54.02 | -4.71 % | $ 1.59 B | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.74 | -0.51 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 85.11 | -1.8 % | $ 2.96 B | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.68 | 0.38 % | $ 122 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 77.87 | -1.62 % | $ 45.5 B | USA |